noThumbs = true, sDelay = 8000

Comprehensive Care for Treatment
of Clinical Neurogenetic Disorders
at Stanford Hospital & Clinics

Stanford Clinical Neurogenetic Disorders

Treatment of Clinical
Neurogenetic Disorders

Refer a Patient Make an Appointment Maps & Directions

The Stanford Clinical Neurogenetic Oncology Program is the first clinic in Northern California to offer world-class care for patients with clinical neurogenetic disorders, which can cause tumors to grow inside the brain, spinal cord, organs, skin and skeletal bones.

Our specialists are committed to providing patients with detailed, ongoing comprehensive disease management for these chronic disorders. The multidisciplinary care team includes neurosurgery, neurology, neuro-opthamalogy, neuro-radiology, neuro-oncology, neuro-interventional radiology, dermatology and genetic specialists dedicated to providing patient-centered care with state-of-the-art services, including:

Comprehensive evaluations that may include radiographic images, neuropsychology evaluation, neuro-diagnostic evaluation, eye and hearing evaluation, genetic testing, and laboratory testing
Diagnostic testing including MRI, CT and PET imaging
Personal treatment plan that may include Cyberknife radiosurgery, neuro-interventional radiology procedures, and neurosurgical interventions
Ongoing clinical/radiological monitoring and surveillance

Neurogenetic Disorders Specialty Expertise

Our team has extensive expertise in handling the most complicated cases including autosomal dominant diseases: Neurofibromatosis (NF) Type 1 and Type 2 , Schwannomatosis, Von Hippel-Lindau, Tuberous Sclerosis, Sturge Weber Syndrome; and autosomal recessive diseases such as Hemorrhagic Telangiectasia. Working with our neurology colleagues, we are also able to evaluate and manage other neurogenetic disorders, such as the genetics of movement disorders and neuromuscular diseases.

Research

Specialists in the Stanford Clinical Neurogenetic Oncology Program pursue a broad range of research projects designed to improve the diagnosis and treatment of patients affected by neurological conditions. Learn more at the Stanford Neuromolecular Innovation Program.